Rama Phosphates quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	225	190	+18.1%
EBITDA	27.9	26.3	+6.1%
EBITDA margin	12.4%	13.8%	−1.4 pts
Profit before tax	22.8	21.5	+6.3%
Net profit	17.1	16.0	+6.4%
EPS	₹4.82	₹4.53	+6.4%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Q2 FY24Sep 2023

Expenses
	225	219	238	246	190	201	180	209	154	186	116	171
	0.8	0.7	0.2	0.3	0.6	2.1	0.2	0.4	0.2	0.5	0.1	0.3
	226	220	238	246	191	203	180	210	154	187	116	172
	171	162	160	129	129	136	127	109	113	136	145	103
	0.1	6.0	19.8	3.2	2.4	6.4	1.9	1.0	2.5	1.5	0.5	0.4
	−25.4	−10.2	−16.9	28.8	−7.6	−15.5	−1.0	41.2	−1.4	0.0	−26.5	30.0
	9.5	11.3	9.0	8.9	8.9	10.1	8.5	8.7	7.6	8.7	6.8	8.1
	4.1	1.9	3.0	2.2	3.5	3.9	3.2	3.5	2.6	3.9	2.9	2.9
	1.8	1.9	2.0	2.0	2.0	2.0	2.1	2.0	2.0	1.7	2.3	2.5
	41.4	39.7	42.5	48.8	31.1	46.3	33.4	38.9	25.4	40.0	23.1	24.2
	203	213	219	223	169	190	175	204	152	192	154	171
	27.9	10.0	23.9	26.8	26.3	17.4	10.1	10.5	6.1	0.2	−32.4	5.7
	26.1	8.1	21.9	24.8	24.3	15.3	8.0	8.5	4.1	−1.5	−34.7	3.3
Profit
	22.8	6.8	19.1	22.9	21.5	13.5	5.1	5.4	1.6	−4.9	−37.5	0.7
	22.8	6.8	19.1	22.9	21.5	13.5	5.1	5.4	1.6	−4.9	−37.5	0.7
	5.7	1.4	4.9	6.1	1.7	5.0	0.0	0.4	0.0	0.0	−0.4	0.2
	0.0	0.1	0.2	−0.5	3.7	3.2	1.4	1.9	−5.2	−2.6	−7.4	−0.1
	5.7	1.5	5.1	5.6	5.4	8.3	1.4	2.3	−5.2	−2.6	−7.8	0.0
	17.1	5.4	14.0	17.3	16.0	5.2	3.7	3.1	6.8	−2.3	−29.7	0.7
	17.1	5.4	14.0	17.3	16.0	5.2	3.7	3.1	6.8	−2.3	−29.7	0.7
	−0.1	0.2	−0.1	−0.1	−0.1	−0.4	0.0	−0.0	0.1	76.7	0.0	−0.0
	17.0	5.5	13.9	17.2	15.9	4.8	3.7	3.1	6.9	74.3	−29.7	0.6
Per share
	₹4.82	₹1.52	₹3.96	₹4.88	₹4.53	₹1.48	₹1.03	₹1.74	₹3.84	−₹1.31	−₹16.81	₹0.38
	₹4.82	₹1.52	₹3.96	₹4.88	₹4.53	₹1.48	₹1.03	₹1.74	₹3.84	−₹1.31	−₹16.81	₹0.38
Profit build-up — alternate / pre-Ind-AS tags
	—	—	—	—	—	13.5	—	—	—	—	—	—
	—	—	—	—	—	5.2	—	—	—	—	—	—
Continuing & discontinued operations
	—	—	—	—	—	5.2	—	—	—	—	—	—
Other comprehensive income — detail
	−0.1	0.2	−0.1	−0.1	−0.1	−0.4	—	—	—	—	—	—
	−0.1	0.2	−0.2	−0.1	−0.1	−0.6	0.0	−0.0	0.1	94.9	0.0	−0.0
	−0.0	0.0	−0.0	−0.0	−0.0	−0.2	—	—	—	—	—	—
	—	—	—	—	—	—	0.0	−0.0	0.0	18.2	−0.0	−0.0
	0.0	—	−0.0	—	—	0.0	—	—	—	—	—	—
Per share — as-filed variants
	₹4.82	₹1.52	₹3.96	₹4.88	₹4.53	₹1.48	₹1.03	₹1.74	₹3.84	−₹1.31	−₹16.81	₹0.38
	₹4.82	₹1.52	₹3.96	₹4.88	₹4.53	₹1.48	₹1.03	₹1.74	₹3.84	−₹1.31	−₹16.81	₹0.38
Regulatory disclosures — filed alongside, not part of the P&L
	—	63.6	—	38.9	—	16.4	—	—	—	—	—	—
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	78.7	61.0	75.4	84.5	66.2	73.8	52.0	58.2	39.1	48.9	−2.5	38.1
	35.0%	27.9%	31.7%	34.4%	34.8%	36.7%	29.0%	27.8%	25.4%	26.2%	−2.2%	22.2%
Adjusted (ex-exceptional items) — derived
	22.8	6.8	19.1	22.9	21.5	13.5	5.1	5.4	1.6	−4.9	−37.5	0.7
	17.1	5.4	14.0	17.3	16.0	5.2	3.7	3.1	6.8	−2.3	−29.7	0.7
	₹4.82	₹1.52	₹3.96	₹4.88	₹4.53	₹1.48	₹1.03	₹1.74	₹3.84	−₹1.31	−₹16.81	₹0.38

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

RAMAPHO₹99.00

Rama Phosphates Limited

· Chemicals

Annual Quarterly₹ CrorePeersKHAICHEM ARIES ZUARI MADRASFERT SPICMcap ₹350 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY24 30/09/2023	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	171.4	116.2	186.2	153.7	209.5	179.6	200.9	190.3	245.7	238.0	219.1	224.8
Other Income	0.3	0.1	0.5	0.2	0.4	0.2	2.1	0.6	0.3	0.2	0.7	0.8
Total Income	171.8	116.2	186.7	153.8	209.8	179.8	203.0	190.9	245.9	238.2	219.7	225.5
Expenses
+ Cost of Materials Consumed	103.0	144.6	135.8	113.5	109.1	126.7	136.2	129.4	129.1	159.8	162.2	171.4
+ Purchases of Stock-in-Trade	0.4	0.5	1.5	2.5	1.0	1.9	6.4	2.4	3.2	19.8	6.0	0.1
+ Changes in Inventories	30.0	-26.5	0.0	-1.4	41.2	-1.0	-15.5	-7.6	28.8	-16.9	-10.2	-25.4
+ Employee Benefit Expense	8.1	6.8	8.7	7.6	8.7	8.5	10.1	8.9	8.9	9.0	11.3	9.5
+ Finance Costs	2.9	2.9	3.9	2.6	3.5	3.2	3.9	3.5	2.2	3.0	1.9	4.1
+ Depreciation & Amortisation	2.5	2.3	1.7	2.0	2.0	2.1	2.0	2.0	2.0	2.0	1.9	1.8
+ Other Expenses	24.2	23.1	40.0	25.4	38.9	33.4	46.3	31.1	48.8	42.5	39.7	41.4
Total Expenses	171.0	153.7	191.6	152.2	204.4	174.8	189.5	169.5	223.0	219.1	212.9	202.7
EBITDA	5.7	-32.4	0.2	6.1	10.5	10.1	17.4	26.3	26.8	23.9	10.0	27.9
EBIT	3.3	-34.7	-1.5	4.1	8.5	8.0	15.3	24.3	24.8	21.9	8.1	26.1
Profit
PBT before Exceptional Items	0.7	-37.5	-4.9	1.6	5.4	5.1	13.5	21.5	22.9	19.1	6.8	22.8
Pretax Income	0.7	-37.5	-4.9	1.6	5.4	5.1	13.5	21.5	22.9	19.1	6.8	22.8
+ Current Tax	0.2	-0.4	0.0	0.0	0.4	0.0	5.0	1.7	6.1	4.9	1.4	5.7
+ Deferred Tax	-0.1	-7.4	-2.6	-5.2	1.9	1.4	3.2	3.7	-0.5	0.2	0.1	0.0
Tax Expense	0.0	-7.8	-2.6	-5.2	2.3	1.4	8.3	5.4	5.6	5.1	1.5	5.7
Net Income	0.7	-29.7	-2.3	6.8	3.1	3.7	5.2	16.0	17.3	14.0	5.4	17.1
+ Net Income — Continuing Ops	0.7	-29.7	-2.3	6.8	3.1	3.7	5.2	16.0	17.3	14.0	5.4	17.1
+ Other Comprehensive Income	-0.0	0.0	76.7	0.1	-0.0	0.0	-0.4	-0.1	-0.1	-0.1	0.2	-0.1
Total Comprehensive Income	0.6	-29.7	74.3	6.9	3.1	3.7	4.8	15.9	17.2	13.9	5.5	17.0
Per Share
Basic EPS	0.38	-16.81	-1.31	3.84	1.74	1.03	1.48	4.53	4.88	3.96	1.52	4.82
Diluted EPS	0.38	-16.81	-1.31	3.84	1.74	1.03	1.48	4.53	4.88	3.96	1.52	4.82
Profit Build-up — Alternate / Pre-Ind-AS Tags
PBT before Exceptional & Extraordinary Items	—	—	—	—	—	—	13.5	—	—	—	—	—
Profit for the Period before Minority Interest	—	—	—	—	—	—	5.2	—	—	—	—	—
Continuing & Discontinued Operations
Profit from Continuing Operations	—	—	—	—	—	—	5.2	—	—	—	—	—
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	—	-0.4	-0.1	-0.1	-0.1	0.2	-0.1
+ Items NOT to be Reclassified to P&L	-0.0	0.0	94.9	0.1	-0.0	0.0	-0.6	-0.1	-0.1	-0.2	0.2	-0.1
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	—	-0.2	-0.0	-0.0	-0.0	0.0	-0.0
+ Tax on Items NOT to be Reclassified — alt tag	-0.0	-0.0	18.2	0.0	-0.0	0.0	—	—	—	—	—	—
+ Tax on Items to be Reclassified	—	—	—	—	—	—	0.0	—	—	-0.0	—	0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	0.38	-16.81	-1.31	3.84	1.74	1.03	1.48	4.53	4.88	3.96	1.52	4.82
Diluted EPS — Continuing Operations	0.38	-16.81	-1.31	3.84	1.74	1.03	1.48	4.53	4.88	3.96	1.52	4.82
Regulatory Disclosures — filed alongside, not part of the P&L
Related-party Transactions — During the Period	—	—	—	—	—	—	16.4	—	38.9	—	63.6	—
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	38.1	-2.5	48.9	39.1	58.2	52.0	73.8	66.2	84.5	75.4	61.0	78.7
Gross Margin %	22.21	-2.16	26.24	25.44	27.80	28.95	36.71	34.80	34.39	31.66	27.87	35.03
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	0.7	-37.5	-4.9	1.6	5.4	5.1	13.5	21.5	22.9	19.1	6.8	22.8
Net Income Adj (tax-effected)	0.7	-29.7	-2.3	6.8	3.1	3.7	5.2	16.0	17.3	14.0	5.4	17.1
EPS Adj	0.38	-16.81	-1.31	3.84	1.74	1.03	1.48	4.53	4.88	3.96	1.52	4.82
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00	5.00	5.00	5.00	5.00	5.00	5.00	5.00
Filed Debt Equity	—	—	—	—	—	—	0.33	0.33	0.25	0.30	0.32	0.37
Filed Dscr	—	—	—	—	—	—	2.04	5.98	6.24	9.30	4.74	4.29
Filed Iscr	—	—	—	—	—	—	3.56	7.10	11.35	7.32	4.57	6.63
Paid Up Equity Capital	17.7	17.7	17.7	17.7	17.7	17.7	17.7	17.7	17.7	17.7	17.7	17.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Rama Phosphates quarterly results

Rama Phosphates (NSE: RAMAPHO) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹17.1 crore, up 6.4% from ₹16 crore in Q1 FY26 and up 218.0% from ₹5.4 crore in Q4 FY26. Revenue from operations was ₹225 crore, up 18.1% year on year and up 2.6% from the previous quarter.

Q2 FY26 results (a year earlier): 14 October 2025
Q1 FY27 results (the latest): 24 July 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹17.1 Cr+6.4% vs Q1 FY26+218.0% vs Q4 FY26
Q1 FY27 revenue: ₹225 Cr+18.1% vs Q1 FY26+2.6% vs Q4 FY26
Q1 FY27 operating margin: 11.6%−1.2 pts vs Q1 FY26+7.9 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹17.3 CrRevenue ₹246 Cr
Q1 FY27 EPS (basic): ₹4.82

Questions

When will Rama Phosphates announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 14 October 2025.

What will Rama Phosphates' Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹17.3 crore and revenue from operations ₹246 crore. The latest quarter, Q1 FY27, had a net profit of ₹17.1 crore and revenue of ₹225 crore.

What was Rama Phosphates' net profit in FY26?

Consolidated net profit was ₹52.7 crore in FY26 (April 2025–March 2026), up 285.5% from ₹13.7 crore in FY25. It was a loss of ₹31.1 crore in FY24 and a profit of ₹40.9 crore in FY23: up 28.8% over three years, 8.8% a year on average.

What were Rama Phosphates' Q1 FY27 results?

Consolidated net profit was ₹17.1 crore, up 6.4% from ₹16 crore in Q1 FY26 and up 218.0% from ₹5.4 crore in Q4 FY26. Revenue from operations was ₹225 crore, up 18.1% year on year and up 2.6% from the previous quarter.

How has Rama Phosphates' profit changed over the last four quarters?

Net profit by quarter: ₹17.3 crore in Q2 FY26, ₹14 crore in Q3 FY26, ₹5.4 crore in Q4 FY26 and ₹17.1 crore in Q1 FY27. That is ₹53.7 crore over the four quarters, up 91.7% from ₹28 crore in the four quarters before. Revenue from operations: ₹246 crore, ₹238 crore, ₹219 crore and ₹225 crore.

What was Rama Phosphates' revenue in FY26?

Revenue from operations was ₹893 crore in FY26 (April 2025–March 2026), up 20.1% from ₹744 crore in FY25. It was ₹603 crore in FY24 and ₹875 crore in FY23: up 2.1% over three years, 0.7% a year on average.

Where do these Rama Phosphates figures come from?

From Rama Phosphates' own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.